Macoven Pharmaceuticals LLC, Pernix Therapeutics deal

Pernix acquired partner Macoven for $2.2 million in cash, including $1.2 million in inventory. Previous owners of Macoven included Pernix officers and directors. Last year, Macoven received a non-excl...